EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 48 filers reported holding EPIZYME INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $636,000 | -55.3% | 25,869 | -65.4% | 0.00% | – |
| Q3 2017 | $1,424,000 | -35.4% | 74,762 | -48.8% | 0.00% | -100.0% |
| Q2 2017 | $2,203,000 | +45.4% | 145,902 | +23.8% | 0.00% | – |
| Q3 2015 | $1,515,000 | -38.1% | 117,843 | +15.6% | 0.00% | -100.0% |
| Q2 2015 | $2,447,000 | -51.2% | 101,963 | -61.8% | 0.00% | 0.0% |
| Q1 2015 | $5,011,000 | +25.8% | 266,801 | +26.4% | 0.00% | 0.0% |
| Q4 2014 | $3,984,000 | -32.4% | 211,141 | -2.9% | 0.00% | -50.0% |
| Q3 2014 | $5,896,000 | -15.8% | 217,511 | -3.4% | 0.00% | 0.0% |
| Q2 2014 | $7,004,000 | +46.6% | 225,051 | +7.3% | 0.00% | +100.0% |
| Q1 2014 | $4,777,000 | +1.0% | 209,781 | -7.7% | 0.00% | 0.0% |
| Q4 2013 | $4,729,000 | -52.1% | 227,370 | -7.6% | 0.00% | -66.7% |
| Q3 2013 | $9,874,000 | +70.2% | 246,070 | +19.3% | 0.00% | +50.0% |
| Q2 2013 | $5,803,000 | – | 206,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |